Cosmetic/Aesthetic
Allergan resists $47B offer by swallowing poison pill
Ulthera registers for $86M IPO
Ulthera filed for a U.S. initial public offering yesterday, saying it hopes to raise as much as $86 million when it debuts on the NASDAQ stock exchange.
Mesa, Ariz.-based Ulthera makes an ultrasound device, which is designed to use the body’s natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.
Breast implant maker GC Aesthetics reels in $60M
GC Aesthetics brought $60 million from 3 healthcare investment groups it plans to use to expand its breast implant business.
Dublin-based GC Aesthetics is the umbrella company for 2 different brands, Nagor and Eurosilicone.The funding round was led by a $40 million contribution from OrbiMed, with existing backers Montreux Equity Partners and Oyster Capital contributing the rest.
Syneron names new CEO, beats The Street and buys New Star Lasers
Israeli device maker Syneron Medical Ltd. (NSDQ:ELOS) made some major moves this month, announcing a new CEO alongside strong Q4 earnings and signing a deal to acquire New Lasers Inc.
Miramar Labs pulls in $10M Series D round
Miramar Labs said it landed a $10 million Series D round it plans to use to boost sales of its miraDry system.
Sunnyvale, Calif.-based Miramar makes dermatology devices including its flagship miraDry system, a laser-based treatment for excessive underarm sweat. The device, which uses microwave energy to eliminate sweat glands, recently won CE Mark approval in the European Union.
DEKA Medical lands clearance for cosmetic laser
DEKA Medical won 510(k) clearance from the FDA for its Synchro REPLA:Y laser. The device is indicated for the treatment of a variety of aesthetic treatments.
Kinetic Concepts touts tissue injector acquisition
Kinetic Concepts sister company LifeCell this week announced the acquisition of fat-injection devices from California medtech group TauTona.
LifeCell hopes to use the deal, the details of which were not disclosed, to expand its reconstructive and cosmetic portfolio with the fat grafting technology.
Valeant closes $250M acquisition of Solta Medical
Cynosure’s tattoo removal laser tech wins approval in South Korea, Taiwan
SkinRex issued FDA warning letter
Korean cosmetic medical device company SkinRex Co. is in hot water with the FDA after the federal watchdog agency issued a warning letter over the marketing of its Cavi-Lipo device.
Seoul-based Skinrex is focused on skincare and weight issues. The company, founded in 2002, is led by Se-Yeong Choi and markets 3 products.